Search research articles
Contact Us
Filters
Showing results (111-120 of 172) with videos related to
Page
of 18
Sort By:
Antimicrobial Agents and Chemotherapy
|
June 15, 2011
LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States
David J Farrell, Rodrigo E Mendes, James E Ross, et al.
Antimicrobial Agents and Chemotherapy
|
January 7, 2015
Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 14, 2013
Antimicrobial susceptibilities of clinical isolates of HACEK organisms
Bryan Coburn, Baldwin Toye, Prasad Rawte, et al.
The Pediatric Infectious Disease Journal
|
September 16, 2014
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012)
Helio S Sader, Rodrigo E Mendes, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
October 11, 2011
Surveillance of JNJ-Q2 activity tested against Staphylococcus aureus and beta-hemolytic streptococci as a component of the 2010 SENTRY Antimicrobial Surveillance Program
David J Farrell, Lisa C Liverman, Douglas J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease
|
January 26, 2015
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program
Helio S Sader, Robert K Flamm, Jennifer M Streit, et al.
Journal of Clinical Microbiology
|
November 6, 2015
Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants
Rodrigo E Mendes, Amy A Watters, Paul R Rhomberg, et al.
Diagnostic Microbiology and Infectious Disease
|
October 8, 2013
Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada
Samir N Patel, Nader Memari, Dea Shahinas, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Telavancin activity when tested by a revised susceptibility testing method against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide (2011-2013)
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 172) with videos related to
Sort By:
Page
of 18
Antimicrobial Agents and Chemotherapy
|
June 15, 2011
LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States
David J Farrell, Rodrigo E Mendes, James E Ross, et al.
Antimicrobial Agents and Chemotherapy
|
January 7, 2015
Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 14, 2013
Antimicrobial susceptibilities of clinical isolates of HACEK organisms
Bryan Coburn, Baldwin Toye, Prasad Rawte, et al.
The Pediatric Infectious Disease Journal
|
September 16, 2014
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012)
Helio S Sader, Rodrigo E Mendes, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
October 11, 2011
Surveillance of JNJ-Q2 activity tested against Staphylococcus aureus and beta-hemolytic streptococci as a component of the 2010 SENTRY Antimicrobial Surveillance Program
David J Farrell, Lisa C Liverman, Douglas J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease
|
January 26, 2015
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program
Helio S Sader, Robert K Flamm, Jennifer M Streit, et al.
Journal of Clinical Microbiology
|
November 6, 2015
Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants
Rodrigo E Mendes, Amy A Watters, Paul R Rhomberg, et al.
Diagnostic Microbiology and Infectious Disease
|
October 8, 2013
Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada
Samir N Patel, Nader Memari, Dea Shahinas, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Telavancin activity when tested by a revised susceptibility testing method against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide (2011-2013)
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Page
of 18